Researchers followed 341 children with familial hypercholesterolemia—a genetic condition that causes dangerously high cholesterol from birth—for three years to see how doctors were treating them. They found that while more kids started taking cholesterol-lowering medicines over time, most still weren’t reaching healthy cholesterol levels. The study shows that doctors often wait too long to start treatment and don’t always use the strongest medicines available. This matters because kids with this genetic condition have a much higher risk of heart disease later in life, so catching and treating it early could save lives.
The Quick Take
- What they studied: How quickly doctors start treating children with a genetic condition that causes very high cholesterol, what medicines they use, and whether the treatment actually brings cholesterol levels down to safe ranges.
- Who participated: 341 children and teenagers (average age 10.8 years) from Italy who had the genetic high-cholesterol condition but weren’t taking any cholesterol medicine when the study started.
- Key finding: After one year, only about half the kids started taking medicine. By year three, nearly 80% were on treatment. However, only about 1 in 4 kids actually reached the healthy cholesterol targets their doctors recommended. The strongest combination treatment (two medicines together) worked best, lowering cholesterol by about 50%.
- What it means for you: If your child has been diagnosed with familial hypercholesterolemia, this research suggests you should talk to your doctor about starting treatment sooner rather than later, and ask about combination therapy if single medicines aren’t working well enough. Don’t accept ‘wait and see’—early treatment can prevent serious heart problems decades later.
The Research Details
This study looked at real-world medical records from an Italian registry (a database) of children with familial hypercholesterolemia. Researchers tracked 341 children who weren’t taking any cholesterol medicine at the start and followed them for three years. They recorded when kids started treatment, what medicines doctors prescribed, and how much their cholesterol levels dropped. The researchers compared different treatment approaches to see which ones worked best.
The study is valuable because it shows what actually happens in regular doctor’s offices and hospitals, not just what happens in controlled research settings. The three-year follow-up period is long enough to see real patterns in how doctors treat this condition and whether treatments are actually working.
Understanding how children with genetic high cholesterol are actually being treated in real life is important because it reveals gaps between what medical guidelines recommend and what doctors actually do. This type of ‘real-world’ research helps doctors improve their practices and helps families know what to expect and advocate for.
This study has good strengths: it tracked a reasonably large group of children over three years, used actual medical records rather than relying on memory, and came from a well-organized registry. However, it only included Italian children, so results might be different in other countries. The study describes what happened but doesn’t prove that one treatment is definitely better than another—it just shows patterns in how doctors treated these kids.
What the Results Show
The research found that treatment of children with familial hypercholesterolemia happens slowly. In the first year, only about half (51.6%) of the untreated children started taking cholesterol medicine. By the end of three years, this increased to nearly 4 out of 5 children (78.9%), with an average age of about 11 years when treatment started.
When doctors did prescribe medicine, they most often chose statins (a common cholesterol-lowering drug) for about 44% of kids, especially those 8 years and older. About 11.5% of children received a combination of statin plus ezetimibe (a second medicine that works differently). Younger children (under 8 years) were more likely to receive ’nutraceuticals’—natural supplements rather than prescription medicines.
The medicines did help lower cholesterol. On average, cholesterol dropped by about 26% with treatment. When kids took the combination of two medicines, cholesterol dropped by about 50%—much better results. However, only about 1 in 4 children (26.1%) actually reached the cholesterol targets that medical guidelines recommend as safe. Kids on combination therapy had the best success rate at reaching these goals.
Children with higher cholesterol levels at the start of the study tended to begin treatment sooner than those with lower levels, which makes sense—doctors were responding to more severe cases. The study also found that despite having more treatment options available, many children remained untreated or under-treated, suggesting doctors weren’t always being aggressive enough with this serious genetic condition.
Previous research has shown that familial hypercholesterolemia significantly increases the risk of heart disease in adulthood. This study confirms what other researchers have found: there’s often a delay between diagnosis and treatment (’therapeutic inertia’), and many patients don’t reach recommended cholesterol targets. This new study adds important information about how this problem specifically affects children in real-world settings.
This study only included children from Italy, so results might be different in other countries with different healthcare systems or treatment practices. The study describes patterns but doesn’t explain why doctors made certain choices—we don’t know if delays were due to doctor hesitation, family preferences, cost, or other factors. The study also didn’t track what happened after three years, so we don’t know long-term outcomes.
The Bottom Line
If your child has been diagnosed with familial hypercholesterolemia: (1) Don’t delay starting treatment—early intervention is important for long-term heart health (HIGH confidence); (2) Ask your doctor about combination therapy (two medicines together) if a single medicine isn’t bringing cholesterol down enough (MODERATE-HIGH confidence); (3) Get regular cholesterol checks to make sure treatment is working (HIGH confidence); (4) Combine medicine with healthy lifestyle choices like diet and exercise (HIGH confidence).
This research is most relevant for families with children diagnosed with familial hypercholesterolemia, their doctors, and healthcare systems designing treatment protocols. It’s less relevant for children without this genetic condition. If you have a family history of early heart disease or high cholesterol, ask your doctor about genetic testing for your children.
Cholesterol-lowering medicines can start working within weeks, but it typically takes 4-12 weeks to see the full effect. You should expect to see meaningful cholesterol reduction within 3 months of starting treatment. Long-term benefits for heart health develop over years and decades of maintaining healthy cholesterol levels.
Want to Apply This Research?
- Track your child’s cholesterol levels every 3 months (or as recommended by your doctor), recording the LDL cholesterol number specifically. Create a simple chart showing the trend over time to discuss with your doctor at each visit.
- Set a reminder to take cholesterol medicine at the same time each day. If your child is old enough, involve them in tracking their own medication adherence using the app’s reminder feature. Also track diet changes—log meals high in fiber and low in saturated fat to support medication effectiveness.
- Create a long-term dashboard showing: (1) medication adherence rate, (2) cholesterol levels at each test, (3) progress toward your doctor’s cholesterol goal, and (4) lifestyle factors like diet quality and physical activity. Share this data with your child’s doctor at each visit to ensure treatment is optimized.
This research describes treatment patterns for familial hypercholesterolemia in children but does not constitute medical advice. Familial hypercholesterolemia is a serious genetic condition requiring professional medical management. If your child has been diagnosed with this condition or has a family history of early heart disease, consult with a pediatric cardiologist or lipid specialist to develop an appropriate treatment plan. Do not start, stop, or change any medications without medical supervision. The findings presented are from one study and should be considered alongside current medical guidelines and your child’s individual health situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.